Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Diabetes

NHS England to fund flash glucose monitoring devices for all eligible diabetes patients

Eligible patients with type 1 diabetes will be able to get a flash glucose monitoring device on prescription in England from April 2019.

Freestyle Libre device

Source: Dr P. Marazzi / Science Photo Library

The Freestyle Libre device enables patients to have their glucose levels relayed electronically to a smart phone or e-reader

All patients with diabetes who qualify for a flash glucose monitoring device will be able to receive it on prescription from April 2019, NHS England has announced.

The Freestyle Libre device, which is the size of a £2 coin and sits on the arm, will enable patients with type 1 diabetes to do away with finger prick blood tests and instead see their glucose levels relayed electronically to a smart phone or e-reader.

The announcement comes after an investigation by The BMJ on 7 November 2018 revealed that tens of thousands of type 1 diabetes patients were missing out on the benefits of the device because some clinical commissioning groups (CCGs) were offering it under more stringent criteria than others, creating a postcode lottery.

In a statement, NHS England said that up to 5% of patients with type 1 diabetes in England currently have access to Freestyle Libre but added that “if CCGs followed guidance correctly, this figure could eventually rise to at least 20–25%”.

NHS England has said it will invest up to £910 per year per patient to enable all eligible patients to access the device on prescription from their GP or diabetes team throughout the country from 1 April 2019.

“Supporting people with modern tools to manage conditions such as type 1 diabetes is about to become much more widespread. Innovations such as these also free up time and resources for the NHS as a whole,” said Simon Stevens, chief executive of NHS England.  

“As the NHS prepares to put digital health and technology at the heart of our long-term plan for the future, NHS England is taking important action so that regardless of where you live, if you’re a patient with type 1 diabetes you can reap the benefits of this life improving technology.”

 

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2018.20205751

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 1 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £138.50Buy now
  • Sport and Exercise Medicine for Pharmacists

    Sport and Exercise Medicine for Pharmacists

    All the information you need to provide patients with evidence-based advice on sports and exercise related health matters.

    £27.00Buy now
  • Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.

    £38.00Buy now
  • Workplace Drug Testing

    Workplace Drug Testing

    Explains drug testing regulatory frameworks and all aspects of drug analysis. Case studies of successful programmes are included.

    £81.00Buy now
  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £38.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.